 |
| Michael R. Elliott, Ph.D., conducts research focused on innate immunity, macrophage biology, and cancer immunotherapy. |
“Dr. Elliott is an excellent addition to our faculty, bringing expertise in immunology that will strengthen the research and teaching mission of the University of South Alabama and USA Health,” said Kevin R. Macaluso, Ph.D., professor and Locke Distinguished Chair of Microbiology and Immunology at the Whiddon College of Medicine.
He most recently served as an associate professor of microbiology, immunology, and cancer biology at the University of Virginia School of Medicine. He will continue as an adjunct associate professor there. Elliott has received numerous awards, and his research has been and continues to be funded by federal grants.
Elliott will conduct research at a new lab at the USA Health Mitchell Cancer Institute. His research interests focus on innate immunity, macrophage biology, and cancer immunotherapy.
Macrophages are a highly diverse, specialized population of immune cells that reside in every tissue in the body. These cells play key roles in maintaining normal tissue function and immune defense against pathogens. The goal of Elliott’s work is to understand the function of tissue-resident macrophages as regulators of innate immunity in cancer immunotherapy, acute and chronic inflammation, aging, and microbial infection.
“USA and MCI provide a great environment for biomedical research and training,” Elliott said. “I am excited about the future of research at South Alabama and look forward to contributing to this through our work in basic immunology and cancer immunotherapy.”
Elliott received his bachelor’s degree from Wake Forest University and his Ph.D. from the Wake Forest University School of Medicine.
